COVID-19 Therapy Resources
Monoclonal Antibody (mAb) infusions in Urgent Care
UCA has been working with HHS and others in hopes that urgent care centers may implement mAb infusions to treat milder coronavirus cases. We continue to be encouraged with rapid improvements made in the drug and interest from HHS in removing challenges and barriers to widespread UCC participation.
The College of Urgent Care Medicine’s Clinical Response Task Force presented its next Listserv Live Event on Wednesday March 31st. Our primary presenter was Jeffrey D. Klausner, MD, MPH with the division of disease prevention, policy and global health at the University of Southern California’s Keck School of Medicine. The focus of Dr. Klausner’s presentation was on the state of the evidence of existing oral therapies for COVID-19 outpatient treatment. Due to the rapidly changing clinical environment, there will also be an update on the status of COVID-19 vaccines and monoclonal antibody therapeutics.
Assistant Secretary for Preparedness and Response (ASPR) - Use of COVID 19 Monoclonal Antibodies in Urgent Care Centers
COVID-19 Monoclonal Antibody Therapeutics Direct Order Process Fact Sheet (pdf)
COVID-19 Monoclonal Antibody Therapeutics Key Resources for Providers Fact Sheet (pdf)
COVID19 Monoclonal Therapeutics UCA Letter to Members (Word)
This message is from the UCA COVID-19 LISTSERV where UCA members can voice their opinions and share information. The opinions expressed are those of the individual and not necessarily those of the Urgent Care Association. For current guidelines and information always refer to the CDC coronavirus information page and your local health department.
Not a member? Individuals join now. | Vendors - interested in becoming a member? Join now.
Search COVID-19 risk assessment by country larger map
Guidance for cleaning and disinfecting a public space, facility, or business to prevent the spread of COVID-19.
CDC's considerations for wearing masks.
Coronavirus (COVID-19) Home Page
Masks help stop the spread of COVID-19 to others. Find out how to wear, clean, and make masks.
Vaccine manufacturers; the federal government; state, local, and territorial jurisdictions; and other partners are working to make sure safe and effective vaccines are getting to you as quickly as possible. This page will help you understand the key steps in this important process and how CDC is tracking vaccine distribution, delivery, and administration throughout the United States.
Because the supply of COVID-19 vaccine in the United States is expected to be limited at first, CDC recommends that initial supplies of COVID-19 vaccine be allocated to healthcare personnel and long-term care facility residents. CDC made this recommendation on December 3, 2020, and based it on recommendations from the Advisory Committee on Immunization Practices (ACIP), an independent panel of medical and public health experts.
The risk of severe illness from COVID-19 increases with age, which is why the CDC recommends older adults receive COVID-19 vaccines.
Adults of any age with certain underlying medical conditions are at increased risk for severe illness from the virus that causes COVID-19. COVID-19 vaccines are recommended for and can be administered to most people with underlying medical conditions.
This webpage provides information for people with disabilities or conditions that may increase their risk of getting and spreading COVID-19, and for their care providers.
Urgent Care Association
28600 Bella Vista Pkwy, Suite 2010
Warrenville, IL 60555
Subscribe to the UCAccess Newsletter